🇺🇸 Eli Lilly and Company vs 🇰🇷 Celltrion — Market Cap Comparison

Based on a unified board of 300 KR·US·JP stocks · updated July 16, 2026 at 02:07 AM KST

👑 🇺🇸 Eli Lilly and Company#13 global$1.02T
🇰🇷 Celltrion#181 global$27B

Eli Lilly and Company is 37.2× Celltrion

Cap gap
$993B
37.2× ratio
Rank gap
168
#13 vs #181
🇺🇸 Eli Lilly and Company
#12 in US
Healthcare
🇰🇷 Celltrion
#18 in Korea
Healthcare

As of July 16, 2026 at 02:07 AM KST, Eli Lilly and Company (LLY) has a market cap of $1.02T — #13 worldwide — while Celltrion (068270.KS) stands at $27B, ranking #181. The gap is $993B; Celltrion is 2.7% the size of Eli Lilly and Company.

Eli Lilly and Company ranks #12 among US stocks (Healthcare), and Celltrion ranks #18 among Korea stocks (Healthcare).

If Celltrion reached Eli Lilly and Company's market cap, its share price would need to go from $118.09 to $4387.41 (about +3615%).

🇺🇸 Eli Lilly and CompanyDetails →🇰🇷 CelltrionDetails →

🆚 More comparisons